Get the latest on Cellectar Biosciences' Q3 2025 earnings, EMA progress for iopofosine, clinical pipeline updates, and strategic outlook.
TipRanks on MSN
Cellectar Biosciences Reports Q3 2025 Financial Progress
Cellectar Biosciences Inc ( ($CLRB) ) has released its Q3 earnings. Here is a breakdown of the information Cellectar Biosciences Inc presented to ...
Good morning, ladies and gentlemen, and welcome to the Cellectar Biosciences' Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025. I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback